Skip to main content
Equibles
MEDP logo

MEDP · Medpace Holdings, Inc.

Track MEDP — free

Use MEDP with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$591.29 -2.10 (-0.35%) At close · Sep 4
S&P 400 member Russell 1000 member Rebalance outlook locked
Market Cap
$16.50B
Shares
27.91M

MEDP metrics

76 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$591.29
Market cap
$16.50B

Price action

19 metrics
Price change (1W)
-3.0%
Price change (30D)
+1.4%
Price change (3M)
+29.4%
Price change (6M)
+26.4%
Price change (YTD)
+5.7%
Price change (1Y)
+23.3%
Trailing year
Price change (5Y)
+204.0%
52-week high
$620.75
52-week low
$393.42
Change from 52-week high
-4.4%
Change from 52-week low
+50.8%
Annualized volatility
44.6%
Beta
0.8
RSI (14D)
51.6
Price vs SMA 50
+3.6%
Price vs SMA 200
+14.0%
Avg volume (3M)
298,596
Relative volume
0.5
Average dollar volume
$163.74M

Company

3 metrics
Sector
Healthcare
Industry
Diagnostics & Research
Shares outstanding
27.91M

Valuation

12 metrics
P / E (TTM)
34.8
Trailing earnings · reciprocal yield 2.9%
PEG ratio
0.9
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
5.9×
reciprocal yield 16.9%
P / book
38.0
reciprocal yield 2.6%
FCF yield
4.3%
TTM · current market cap
Buyback yield
1.8%
P / FCF
23.3
reciprocal yield 4.3%
P / operating cash flow
21.9
reciprocal yield 4.6%
Earnings yield
3.0%

Historical valuation

8 metrics
P / E historical average (3Y)
32.4×
reciprocal yield 3.1%
P / E historical average (5Y)
32.1×
reciprocal yield 3.1%
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
1.8%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-07-23

Profitability

9 metrics
Gross margin
—
Operating margin
21.0%
Trailing 12 months
Net margin
17.7%
Gross profit (TTM)
—
Operating profit (TTM)
$583.40M
Net income (TTM)
$491.50M
Trailing 12 months
Diluted EPS (TTM)
$17.04
FCF margin
25.4%
Effective tax rate
17.9%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$12.67

Growth

11 metrics
Revenue growth YoY
+17.2%
Year over year
Net income growth YoY
+34.5%
Revenue (TTM)
$2.78B
Trailing 12 months
EPS growth YoY
+37.1%
Shares change YoY
-2.0%
Year over year · fewer shares
Revenue CAGR (3Y)
+20.1%
Revenue CAGR (5Y)
+22.3%
EPS CAGR (3Y)
+28.0%
EPS CAGR (5Y)
+31.8%
FCF CAGR (3Y)
+24.8%
FCF CAGR (5Y)
+24.6%

Quality

14 metrics
Return on equity
113.3%
Return on assets
23.9%
Debt / equity
—
Current ratio
0.7
EBITDA (TTM)
—
Free cash flow (TTM)
$706.69M
Quick ratio
0.7
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$502.69M
Total assets
$2.06B
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$752.66M
Capital expenditures (TTM)
$45.97M
R&D (TTM)
—
SG&A (TTM)
$189.02M
Stock compensation (TTM)
$21.21M
R&D / revenue
—
Stock compensation / revenue
0.8%

Ownership (13F)

3 metrics
13F filers
695
13F filer change QoQ
-40
Institutional ownership
88.8%

Short interest

3 metrics
Short interest
5.7%
Latest settlement · 7.6 days to cover
Days to cover
7.6d
Short-squeeze score
75 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$82.62M
Insider-sentiment score
4 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1668397 CUSIP 58506Q109 13F (30d) 434 filings 416 filers Visit website Investor relations